These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6360436)

  • 1. Marked reduction of DNA antibody production and glomerulopathy in thymulin (FTS-Zn) or cyclosporin A treated (NZB X NZW) F1 mice.
    Israel-Biet D; Noel LH; Bach MA; Dardenne M; Bach JF
    Clin Exp Immunol; 1983 Nov; 54(2):359-65. PubMed ID: 6360436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: II. Reduction of glomerulonephritis.
    Gunn HC; Ryffel B
    Clin Exp Immunol; 1986 May; 64(2):234-42. PubMed ID: 3742874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective improvement of thymus and some T cell dysfunctions in NZB mice by in utero thymulin treatment.
    Quéré P; Dardenne M; Bach MA
    J Immunol; 1985 Aug; 135(2):1180-5. PubMed ID: 2409141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolongation of life in female NZB/NZW (F1) hybrid mice by cyclosporin A.
    Jones MG; Harris G
    Clin Exp Immunol; 1985 Jan; 59(1):1-9. PubMed ID: 3882281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies.
    Gunn HC
    Clin Exp Immunol; 1986 May; 64(2):225-33. PubMed ID: 3488856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice.
    Okudaira H; Terada E; Okudaira K
    Prog Clin Biol Res; 1987; 229():157-74. PubMed ID: 3601985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early expression in (NZB X DBA/2)F1 hybrids of thymus dysfunction and abnormal antibody production inherited from the NZB parent.
    Quere P; Savino W; Dardenne M; Bach MA
    Eur J Immunol; 1985 Feb; 15(2):112-7. PubMed ID: 3871696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice.
    Dong L; Ito S; Ishii KJ; Klinman DM
    Arthritis Rheum; 2005 Feb; 52(2):651-8. PubMed ID: 15692999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
    Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ
    Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
    Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB
    Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis.
    Sato MN; Minoprio P; Avrameas S; Ternynck T
    Immunology; 1995 May; 85(1):26-32. PubMed ID: 7635519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceleration of glomerulonephritis in NZB x NZW mice by early immunization with DNA and injection of bacterial lipopolysaccharide. Experimental approach to the treatment of lupus nephritis by use of the accelerated model of NZB x NZW mouse disease.
    Fournie GJ; Minh MG; Mignon-Conte MA; Hass S; Lambert PH; Conte JJ
    J Clin Lab Immunol; 1980 Sep; 4(2):103-6. PubMed ID: 7441709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the spontaneous systemic autoimmune disease in (NZB x NZW)F1 mice by treatment with thimerosal (ethyl mercury).
    Havarinasab S; Hultman P
    Toxicol Appl Pharmacol; 2006 Jul; 214(1):43-54. PubMed ID: 16443248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymic hormone containing cells. II. Evolution of cells containing the serum thymic factor (FTS or thymulin) in normal and autoimmune mice, as revealed by anti-FTS monoclonal antibodies. Relationship with Ia bearing cells.
    Savino W; Dardenne M; Bach JF
    Clin Exp Immunol; 1983 Apr; 52(1):1-6. PubMed ID: 6345030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein.
    Rodriguez W; Mold C; Kataranovski M; Hutt J; Marnell LL; Du Clos TW
    Arthritis Rheum; 2005 Feb; 52(2):642-50. PubMed ID: 15692982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of anti-DNA antibodies from serum and kidney eluates of NZB x NZW F1 mice.
    Dang H; Harbeck RJ
    J Clin Lab Immunol; 1982 Nov; 9(2):139-45. PubMed ID: 6984079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB x NZW)F(1) mice.
    Zykova SN; Seredkina N; Benjaminsen J; Rekvig OP
    Arthritis Rheum; 2008 Mar; 58(3):813-25. PubMed ID: 18311834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan sulfate staining of the glomerular basement membrane in relation to circulating anti-DNA and anti-heparan sulfate reactivity: a longitudinal study in NZB/W F1 mice.
    Hylkema MN; van Bruggen MC; van de Lagemaat R; Kramers K; Berden JH; Smeenk RJ
    J Autoimmun; 1996 Feb; 9(1):41-50. PubMed ID: 8845053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of development of anti-nuclear antibody and glomerulonephritis in NZB x NZWF1 mice by persistent infection with lactic dehydrogenase virus: possible involvement of superoxide anion as a progressive effector.
    Hayashi T; Noguchi Y; Kameyama Y
    Int J Exp Pathol; 1993 Dec; 74(6):553-60. PubMed ID: 8292553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.